Format

Send to:

Choose Destination
See comment in PubMed Commons below
Blood. 1998 Sep 15;92(6):2177-81.

Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection.

Author information

  • 1Division of Clinical Research, the Fred Hutchinson Cancer Research Center, Seattle, WA; the Departments of Medicine and Pathology, University of Washington, Seattle, WA, USA. pmartin@fhcrc.org

Abstract

Donor CD8 cells play a pivotal role in preventing allogeneic marrow graft rejection, possibly by generating cytotoxic effectors needed to eliminate recipient T cells remaining after the pretransplant conditioning regimen or by producing cytokines needed to support the growth and differentiation of hematopoietic stem cells. In the present study, we assessed the role of donor T-cell cytotoxic effector function as a mechanism for eliminating recipient CD8 cells that cause marrow graft rejection in mice. The ability to prevent rejection was minimally affected by the presence of a defect in Fas ligand binding or by the absence of granzyme B but was severely affected by the absence of perforin. Doubly mutant perforin-deficient, Fas ligand-defective CD8 cells were completely unable to prevent rejection. Our results indicate first that recipient CD8 effectors responsible for causing marrow graft rejection are sensitive to cytotoxicity mediated by both perforin- and Fas-ligand-dependent mechanisms, and second that donor T cells must have at least one functional cytotoxic mechanism to prevent allogeneic marrow graft rejection.

Copyright 1998 by The American Society of Hematology.

PMID:
9731078
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk